Latest

Type 2 Diabetes

·August 1, 2021·7 min read

Treatment Lets Obese Mice Lose Weight by Sweating Fat

Obese mice treated with the TSLP cytokine showed a significant loss in abdominal fat and weight. The fat loss was not associated with reduced food intake or faster metabolism, instead the cytokine stimulated the immune system to release lipids via the skin's oil-producing sebaceous glands.

Featured Neuroscience

·June 8, 2021·2 min read

People Who Have Trouble Sleeping Are at a Higher Risk of Dying, Especially Diabetics

Sleep disruptions have been linked to a higher risk of death, especially in those with type 2 diabetes. Researchers found those with type 2 diabetes who reported frequent sleep disruptions, were 87% more likely to die of any cause than those without diabetes or sleep disturbances. Additionally, those with diabetes and sleep disruptions were 12% more die over a nine-year period than those with diabetes alone.

Featured Neurology Neuroscience

·March 8, 2021·3 min read

Type 2 Diabetes Is Associated With Increased Risk of Parkinson’s

Type 2 diabetes is not only associated with an increased risk of developing Parkinson's disease, but it's also associated with an accelerated progression of Parkinson's symptoms.

Featured Neurology Neuroscience

·September 23, 2020·6 min read

Metformin Treatment Linked to Slowed Cognitive Decline

Metformin, a drug commonly used to treat diabetes, slows cognitive decline and reduces dementia risk in older people with diabetes.

Featured Neurology Open Neuroscience Articles

·September 9, 2020·4 min read

Older Women With Type 2 Diabetes Have Different Patterns of Blood Use in Their Brains

Older women with type 2 diabetes do not use as much oxygenated blood in their brains as those who do not have the disease. Findings demonstrate alterations in neural blood use are a primary reason for deficits in motor function experienced by those with diabetes.

Featured Neurology Neuroscience Open Neuroscience Articles

·September 7, 2020·8 min read

The Brain Can Induce Diabetes Remission in Rodents, but How?

Researchers demonstrate how a single injection of fibroblast growth factor 1 (FGF1) can restore blood sugar levels to normal for extended periods in rodent models of type 2 diabetes. Studies show how FGF1 affects specific neurons and perineuronal nets to help restore blood sugar levels to normal, thus sending diabetes into remission.

Featured Genetics Neurology

·August 21, 2020·4 min read

A Gatekeeper Against Insulin Resistance in the Brain

Summary: In males, a genetic variant of DUSP8 can increase the risk of type 2 diabetes by impairing the brain’s...

Featured Neurology Neuroscience

·May 1, 2020·3 min read

For people with diabetes and COVID-19, blood sugar control is key

It is well reported that diabetes is a risk factor for severe COVID-19 infections and increased mortality risk as a result of the virus. A new study reports those with Type 2 diabetes with well-controlled blood sugar levels fare much better if the contract coronavirus than those with poorly controlled blood glucose levels.

Featured Neurology Neuroscience Open Neuroscience Articles

·April 24, 2020·4 min read

Highlighting diabetes risks in COVID-19

The risk of severe complications, including death, from coronavirus, is almost 50% higher in those with diabetes than the general population. Although it is yet to be verified in humans, new findings suggest diabetes may not only be a risk factor for severe COVID-19, but the infection could result in causing new onset of diabetes due to the damage it causes to pancreatic beta cells.

This shows the interaction between dpp4 and covid19

Featured Genetics Neuroscience Open Neuroscience Articles

·April 13, 2020·2 min read

Could inhibiting the DPP4 enzyme help treat coronavirus?

Previous studies of related coronaviruses SARS and MERS found blocking DPP4 activity reduced inflammatory response. Researchers suggest drugs that target DPP4 could help to reduce the overexpression of inflammatory cytokines seen in severe COVID-19.

Featured Neuroscience Open Neuroscience Articles

·March 3, 2020·5 min read

Artificial sweeteners combined with carbs may be more harmful than sweeteners alone

Consumed alone, artificial sweeteners do not appear to have a negative impact. However, when consumed with carbohydrates, insulin sensitivity changes and the brain has a decreased response to sweet tastes.

Featured Neurology Neuroscience Open Neuroscience Articles Psychology

·February 17, 2020·6 min read

Mortality from all causes over 40% higher in female domestic abuse survivors

Women who have experienced domestic violence are 44% more likely to die from any cause compared to the general population. They also have a 51% increased risk of developing type 2 diabetes and a 31% higher risk of being diagnosed with cardiovascular disease.

1 2 3 4 5 … 10

Type 2 Diabetes

Treatment Lets Obese Mice Lose Weight by Sweating Fat

People Who Have Trouble Sleeping Are at a Higher Risk of Dying, Especially Diabetics

Type 2 Diabetes Is Associated With Increased Risk of Parkinson’s

Metformin Treatment Linked to Slowed Cognitive Decline

Older Women With Type 2 Diabetes Have Different Patterns of Blood Use in Their Brains

The Brain Can Induce Diabetes Remission in Rodents, but How?

A Gatekeeper Against Insulin Resistance in the Brain

For people with diabetes and COVID-19, blood sugar control is key

Highlighting diabetes risks in COVID-19

Could inhibiting the DPP4 enzyme help treat coronavirus?

Artificial sweeteners combined with carbs may be more harmful than sweeteners alone

Mortality from all causes over 40% higher in female domestic abuse survivors

Ultra-Processed Foods Erodes Visual Attention

Why Feeling Good is Harder than Not Feeling Bad

Astrocytes Identified as Key Target for Treating Fragile X Syndrome

Liver Talks to the Brain to Control Appetite

Subscribe